HAEMONETICS CORP insider trading

HAENYSE

$104.68+0.31 (+0.30%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+114.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Unlock quarterly net flow

Key players

CSChristopher SimonPresident & CEO0.9774%of company
MLMichelle L. BasilEVP and General Counsel0.1513%of company
JDJames DAreccaEVP, Chief Financial Officer0.1197%of company
LALaurie A. MillerSVP, Human Resources0.0901%of company
RGRoy GalvinEVP, Chief Commercial Officer0.0877%of company
FCFrank ChanEVP, Chief Operating Officer0.0724%of company
RERobert E. AbernathyDirector0.0605%of company
MWMark W. KrollDirector0.06%of company
CJCharles J. DockendorffDirector0.055%of company
EMEllen M. ZaneDirector0.0482%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
HAE	Mark W. KrollDirector	Open market purchase$98.8K	+6.0%	$70.56	$98.8K	Nov 10, 2025	Nov 12, 2025

End of history · 1 transactions